ID24910A - Karboksilat nukleosid hemisulfat dan penggunaan dalam perlakuan infeksi viral - Google Patents
Karboksilat nukleosid hemisulfat dan penggunaan dalam perlakuan infeksi viralInfo
- Publication number
- ID24910A ID24910A IDW991393A ID991393A ID24910A ID 24910 A ID24910 A ID 24910A ID W991393 A IDW991393 A ID W991393A ID 991393 A ID991393 A ID 991393A ID 24910 A ID24910 A ID 24910A
- Authority
- ID
- Indonesia
- Prior art keywords
- carboxicate
- hemisulfate
- nucleoside
- viral infection
- infection treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Seasonings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9709945.1A GB9709945D0 (en) | 1997-05-17 | 1997-05-17 | A novel salt |
Publications (1)
Publication Number | Publication Date |
---|---|
ID24910A true ID24910A (id) | 2000-08-31 |
Family
ID=10812407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW991393A ID24910A (id) | 1997-05-17 | 1998-05-14 | Karboksilat nukleosid hemisulfat dan penggunaan dalam perlakuan infeksi viral |
Country Status (51)
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9802472D0 (en) * | 1998-02-06 | 1998-04-01 | Glaxo Group Ltd | Pharmaceutical compositions |
HU226998B1 (en) * | 2000-11-23 | 2010-04-28 | Richter Gedeon Nyrt | Desloratadine hemisulphate, process for the preparation thereof and pharmaceutical compositions containing the same |
GB0320738D0 (en) | 2003-09-04 | 2003-10-08 | Glaxo Group Ltd | Novel process |
KR101396686B1 (ko) * | 2006-09-28 | 2014-05-16 | 에스티브 퀴미카 에스.에이. | 아바카비어 조제 방법 |
EP1905772A1 (en) * | 2006-09-28 | 2008-04-02 | Esteve Quimica, S.A. | Process for the preparation of abacavir |
EP2085397A1 (en) | 2008-01-21 | 2009-08-05 | Esteve Quimica, S.A. | Crystalline form of abacavir |
EP2218721A1 (en) * | 2009-02-11 | 2010-08-18 | LEK Pharmaceuticals d.d. | Novel salts of sitagliptin |
EP2305680A3 (en) | 2009-09-30 | 2011-05-18 | Aurobindo Pharma Limited | Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol |
NZ627826A (en) | 2010-01-27 | 2016-01-29 | Viiv Healthcare Co | Antiviral combinations involving (3s,11ar)-n-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide |
CN103282369A (zh) | 2011-04-08 | 2013-09-04 | 劳乐斯实验室私营有限公司 | 抗逆转录病毒化合物与抗氧化酸的固体形式、其制备方法以及其药物组合物 |
JP6391561B2 (ja) | 2013-02-27 | 2018-09-19 | 国立大学法人京都大学 | がんの予防または治療用医薬組成物 |
CN104788451A (zh) * | 2014-01-21 | 2015-07-22 | 浙江九洲药业股份有限公司 | 一种阿巴卡韦的制备方法 |
CN105315280A (zh) * | 2014-06-06 | 2016-02-10 | 上海迪赛诺化学制药有限公司 | 一种阿巴卡韦结晶体及其制备方法 |
US10874687B1 (en) | 2020-02-27 | 2020-12-29 | Atea Pharmaceuticals, Inc. | Highly active compounds against COVID-19 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY104575A (en) * | 1989-12-22 | 1994-04-30 | The Wellcome Foundation Ltd | Therapeutic nucleosides. |
GB9417249D0 (en) * | 1994-08-26 | 1994-10-19 | Wellcome Found | A novel salt |
MY115461A (en) * | 1995-03-30 | 2003-06-30 | Wellcome Found | Synergistic combinations of zidovudine, 1592u89 and 3tc |
HUP9903098A3 (en) * | 1996-06-25 | 2000-01-28 | Glaxo Group Ltd | Combination comprising vx478, zidovudine and/or 1592u89 and pharmaceutical composition containing them |
-
1997
- 1997-05-17 GB GBGB9709945.1A patent/GB9709945D0/en active Pending
-
1998
- 1998-04-15 TN TNTNSN98065A patent/TNSN98065A1/fr unknown
- 1998-05-14 DK DK98925601T patent/DK0983271T3/da active
- 1998-05-14 ID IDW991393A patent/ID24910A/id unknown
- 1998-05-14 UA UA99116246A patent/UA56231C2/uk unknown
- 1998-05-14 DE DE1998621758 patent/DE69821758T2/de not_active Expired - Lifetime
- 1998-05-14 MY MYPI98002147A patent/MY120151A/en unknown
- 1998-05-14 RS YUP-595/99A patent/RS49655B/sr unknown
- 1998-05-14 EP EP98925601A patent/EP0983271B1/en not_active Expired - Lifetime
- 1998-05-14 TR TR1999/02810T patent/TR199902810T2/xx unknown
- 1998-05-14 ES ES98925601T patent/ES2214712T3/es not_active Expired - Lifetime
- 1998-05-14 AR ARP980102251A patent/AR015668A1/es active IP Right Grant
- 1998-05-14 EG EG52698A patent/EG23836A/xx active
- 1998-05-14 PL PL98336888A patent/PL189527B1/pl unknown
- 1998-05-14 AT AT98925601T patent/ATE259811T1/de active
- 1998-05-14 SK SK1561-99A patent/SK285159B6/sk not_active IP Right Cessation
- 1998-05-14 HN HN1998000071A patent/HN1998000071A/es unknown
- 1998-05-14 BR BRPI9809126A patent/BRPI9809126B8/pt not_active IP Right Cessation
- 1998-05-14 EA EA199900944A patent/EA001809B1/ru not_active IP Right Cessation
- 1998-05-14 KR KR10-1999-7010584A patent/KR100521292B1/ko not_active IP Right Cessation
- 1998-05-14 GE GEAP19985087A patent/GEP20022680B/en unknown
- 1998-05-14 AP APAP/P/1999/001688A patent/AP2009A/en active
- 1998-05-14 PA PA19988451301A patent/PA8451301A1/es unknown
- 1998-05-14 EE EEP199900537A patent/EE03924B1/xx unknown
- 1998-05-14 ZA ZA9804083A patent/ZA984083B/xx unknown
- 1998-05-14 ZA ZA9804085A patent/ZA984085B/xx unknown
- 1998-05-14 CO CO98027044A patent/CO4940435A1/es unknown
- 1998-05-14 PT PT98925601T patent/PT983271E/pt unknown
- 1998-05-14 CA CA002289753A patent/CA2289753C/en not_active Expired - Lifetime
- 1998-05-14 CN CNB031029213A patent/CN100408580C/zh not_active Expired - Lifetime
- 1998-05-14 IL IL13279398A patent/IL132793A0/xx active IP Right Grant
- 1998-05-14 HU HU0002754A patent/HU226563B1/hu unknown
- 1998-05-14 GB GB0010222A patent/GB2348202B/en not_active Expired - Lifetime
- 1998-05-14 JP JP54991098A patent/JP3150711B2/ja not_active Expired - Lifetime
- 1998-05-14 AU AU77655/98A patent/AU739953B2/en not_active Expired
- 1998-05-14 CN CNB988070731A patent/CN1150194C/zh not_active Expired - Lifetime
- 1998-05-14 SI SI9830615T patent/SI0983271T1/xx unknown
- 1998-05-14 WO PCT/EP1998/002835 patent/WO1998052949A1/en active Search and Examination
- 1998-05-14 NZ NZ510622A patent/NZ510622A/en not_active IP Right Cessation
- 1998-05-14 GB GB9926839A patent/GB2340491B/en not_active Expired - Lifetime
- 1998-05-14 PE PE1998000374A patent/PE78799A1/es not_active IP Right Cessation
- 1998-05-14 NZ NZ500865A patent/NZ500865A/en not_active IP Right Cessation
- 1998-05-14 US US09/423,982 patent/US6294540B1/en not_active Expired - Lifetime
- 1998-05-15 TW TW087107544A patent/TW480259B/zh not_active IP Right Cessation
- 1998-05-15 HR HR980265A patent/HRP980265B1/xx not_active IP Right Cessation
- 1998-05-15 UY UY25004A patent/UY25004A1/es not_active IP Right Cessation
- 1998-05-15 SV SV1998000057A patent/SV1998000057A/es active IP Right Grant
- 1998-05-16 JO JO19982032A patent/JO2032B1/en active
- 1998-05-17 DZ DZ980103A patent/DZ2493A1/xx active
- 1998-06-21 SA SA98190179A patent/SA98190179B1/ar unknown
-
1999
- 1999-11-08 IL IL132793A patent/IL132793A/en not_active IP Right Cessation
- 1999-11-11 IS IS5246A patent/IS2207B/is unknown
- 1999-11-16 OA OA9900249A patent/OA11304A/en unknown
- 1999-11-16 NO NO19995622A patent/NO324731B1/no not_active IP Right Cessation
- 1999-12-07 BG BG103959A patent/BG64390B1/bg unknown
-
2000
- 2000-03-07 MA MA25078A patent/MA26498A1/fr unknown
- 2000-05-11 JP JP2000138178A patent/JP2000327679A/ja active Pending
- 2000-06-07 HK HK00103423A patent/HK1024236A1/xx not_active IP Right Cessation
-
2007
- 2007-01-02 AR ARP070100006A patent/AR059120A2/es active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT712862E (pt) | Acilacao selectiva de grupos epsilon-amino em ensulina | |
NO992373L (no) | Forlenget anestesi i ledd og kroppshulrom | |
DK1087778T3 (da) | Anvendelse af PEG-IFN-alfa og Ribavirin til behandling af kronisk hepatitis C | |
NO983965D0 (no) | Polymer-organoleire-kompositter og deres fremstilling | |
NO991700D0 (no) | Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer | |
DE69811135D1 (de) | Keramischer Wabenkörper | |
ID24910A (id) | Karboksilat nukleosid hemisulfat dan penggunaan dalam perlakuan infeksi viral | |
ID20600A (id) | Sel-sel yang dimodifikasi secara genetik dan penggunaannya dalam profilaksis atau terapi penyakit | |
DE69707347D1 (de) | Keramischer Wabenkörper | |
PT1017408E (pt) | Utilizacao de tetra-hidrolipstatina no tratamento de diabetes de tipo ii | |
NO984836L (no) | Substituerte benzylaminer og deres anvendelse for behandling av depresjon | |
BR9509641A (pt) | Sequências de dna e seu uso | |
DE59909860D1 (de) | Anwendung von 5'-modifizierten nukleotiden in der molekularbiologie und medizin | |
DE69918447D1 (de) | Antivirale kombinationen von lamivudin und adefovir | |
DK0876146T3 (da) | Nucleoside analoger i kombinationsterapi af herpes simplex infektioner | |
ZA983740B (en) | Novel amidine derivatives and their use in therapy | |
EE200000018A (et) | 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine | |
DE59812220D1 (de) | Halte- und trageband | |
FR2718749B1 (fr) | Vecteurs viraux et utilisation en thérapie génique. | |
ID16730A (id) | Dihidro pirimidina dan penggunaannya | |
BR7400443U (pt) | Disposição introduzida em maleta descartável | |
ID20518A (id) | Turunan-turunan oksazolon dan penggunaannya | |
BA98291A (bs) | Epoksi-azetidinoni priprava i upotreba | |
GB9702184D0 (en) | Improvements in or relating to nucleoside and nucleotide analogues | |
EE00130U1 (et) | Muda-parafiinimarlis |